India’s Pricing Regulator Seeks Review Of ‘New Drug’ Playbook
Executive Summary
Pharmaceutical firms in India may be gaming the system with reference to certain tweaked formulations, and the country’s apex pricing regulator wants the concept of such new drugs to be revisited.